Literature DB >> 34279685

Identification of LIPH as an unfavorable biomarkers correlated with immune suppression or evasion in pancreatic cancer based on RNA-seq.

Hongkai Zhuang1,2, Xinming Chen3, Ying Wang4, Shanzhou Huang2, Bo Chen5, Chuanzhao Zhang6, Baohua Hou7.   

Abstract

BACKGROUND: It is widely considered that pancreatic cancer (PC) is an immunosuppressive cancer. Immune-based therapies remain promising therapeutic strategies for PC. Overexpression of lipase H (LIPH) was reported to be related to immunity in cattle and has also been demonstrated to promote tumor progression in several tumors, but its role in pancreatic carcinogenesis remains unclear. Study on LIPH in PC might provide a new insight into the immunosuppression in PC.
METHODS: The potential biological and clinical significance of LIPH was evaluated by bioinformatics analysis. We further investigated potential associations between the expression of LIPH and tumor immune infiltration using the CIBERSORT algorithm, the ESTIMAT algorithm, and single sample gene set enrichment analysis (ssGSEA).
RESULTS: LIPH was significantly overexpressed in tumor tissues compared with normal tissues. LIPH overexpression correlated with tumor recurrence, advanced histologic grade, and poorer overall survival (OS). Four of the most common somatic mutation, including KRAS, TP53, CDKN2A, and SMAD4, in PC were all correlated with high LIPH expression. And high LIPH expression was significantly correlated with KRAS activation and SMAD4 inactivation. Besides, LIPH expression was involved in various biological pathways such as negative regulation of cell-cell adhesion, actin cytoskeleton, EMT, angiogenesis, and signaling by MST1. And LIPH overexpression caused high infiltration of TAMs, Treg cells, and Th2/Th1, but reduced the infiltration of CD8+ T cells and Th1 cells.
CONCLUSIONS: Our findings demonstrated that LIPH correlated with immune suppression or evasion and may function as a novel unfavorable prognostic biomarker in PC.
© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Immune infiltration; Lipase H (LIPH); Pancreatic cancer (PC); The Cancer Genome Atlas (TCGA); The Gene Expression Omnibus (GEO)

Mesh:

Substances:

Year:  2021        PMID: 34279685     DOI: 10.1007/s00262-021-03019-x

Source DB:  PubMed          Journal:  Cancer Immunol Immunother        ISSN: 0340-7004            Impact factor:   6.968


  54 in total

Review 1.  Two immune faces of pancreatic adenocarcinoma: possible implication for immunotherapy.

Authors:  Alexandr V Bazhin; Ivan Shevchenko; Viktor Umansky; Jens Werner; Svetlana Karakhanova
Journal:  Cancer Immunol Immunother       Date:  2013-10-16       Impact factor: 6.968

2.  Anti-PD1 antibodies in patients aged ≥ 75 years with metastatic melanoma: A retrospective multicentre study.

Authors:  Laura Ridolfi; Francesco De Rosa; Elisabetta Petracci; Enrica Teresa Tanda; Elena Marra; Jacopo Pigozzo; Riccardo Marconcini; Michele Guida; Gian Carlo Antonini Cappellini; Giulia Gallizzi; Marcella Occelli; Laura Pala; Elisabetta Gambale; Melissa Bersanelli; Giovanna Galdo; Alessio Cortellini; Francesca Morgese; Federica Zoratto; Luigia Stefania Stucci; Sabino Strippoli; Massimo Guidoboni
Journal:  J Geriatr Oncol       Date:  2020-01-09       Impact factor: 3.599

Review 3.  New therapeutic targets in pancreatic cancer.

Authors:  Eleonora Lai; Marco Puzzoni; Pina Ziranu; Andrea Pretta; Valentino Impera; Stefano Mariani; Nicole Liscia; Paolo Soro; Francesca Musio; Mara Persano; Clelia Donisi; Simona Tolu; Francesca Balconi; Annagrazia Pireddu; Laura Demurtas; Valeria Pusceddu; Silvia Camera; Francesco Sclafani; Mario Scartozzi
Journal:  Cancer Treat Rev       Date:  2019-11-11       Impact factor: 12.111

Review 4.  Promising new treatments for pancreatic cancer in the era of targeted and immune therapies.

Authors:  Ahmed Elaileh; Ashish Saharia; Lucy Potter; Flavio Baio; Afnan Ghafel; Maen Abdelrahim; Kirk Heyne
Journal:  Am J Cancer Res       Date:  2019-09-01       Impact factor: 6.166

Review 5.  Broadening the Impact of Immunotherapy to Pancreatic Cancer: Challenges and Opportunities.

Authors:  Vinod P Balachandran; Gregory L Beatty; Stephanie K Dougan
Journal:  Gastroenterology       Date:  2019-01-18       Impact factor: 22.682

Review 6.  Pancreatic cancer.

Authors:  Terumi Kamisawa; Laura D Wood; Takao Itoi; Kyoichi Takaori
Journal:  Lancet       Date:  2016-01-30       Impact factor: 79.321

Review 7.  The Evolving Understanding of the Molecular and Therapeutic Landscape of Pancreatic Ductal Adenocarcinoma.

Authors:  Ashleigh Parkin; Jennifer Man; Angela Chou; Adnan M Nagrial; Jaswinder Samra; Anthony J Gill; Paul Timpson; Marina Pajic
Journal:  Diseases       Date:  2018-11-13

8.  Switching to Immune Checkpoint Inhibitors upon Response to Targeted Therapy; The Road to Long-Term Survival in Advanced Melanoma Patients with Highly Elevated Serum LDH?

Authors:  Maartje G Schouwenburg; Karijn P M Suijkerbuijk; Rutger H T Koornstra; Anouk Jochems; Michiel C T van Zeijl; Alfons J M van den Eertwegh; John B A G Haanen; Maureen Jb Aarts; Alexander C J van Akkooi; Franchette W P J van den Berkmortel; Jan Willem B de Groot; Geke A P Hospers; Ellen Kapiteijn; Wim H Kruit; Djura Piersma; Rozemarijn S van Rijn; Albert J Ten Tije; Gerard Vreugdenhil; Jacobus J M van der Hoeven; Michel W J M Wouters
Journal:  Cancers (Basel)       Date:  2019-12-04       Impact factor: 6.639

Review 9.  From bench to bed: the tumor immune microenvironment and current immunotherapeutic strategies for hepatocellular carcinoma.

Authors:  Yaojie Fu; Shanshan Liu; Shan Zeng; Hong Shen
Journal:  J Exp Clin Cancer Res       Date:  2019-09-09

10.  GDF11 induces mild hepatic fibrosis independent of metabolic health.

Authors:  Jan Frohlich; Kristina Kovacovicova; Tommaso Mazza; Maria R Emma; Daniela Cabibi; Michelangelo Foti; Cyril Sobolewski; Jude A Oben; Marion Peyrou; Francesc Villarroya; Maurizio Soresi; Rita Rezzani; Melchiorre Cervello; Francesca Bonomini; Anna Alisi; Manlio Vinciguerra
Journal:  Aging (Albany NY)       Date:  2020-10-28       Impact factor: 5.682

View more
  3 in total

1.  Prognostic Value and Clinical Significance of LIPH in Breast Cancer.

Authors:  Peng Gao; Qiang Liu; Bolun Ai; Yi Fang; Zhongzhao Wang; Jing Wang
Journal:  Int J Gen Med       Date:  2021-11-02

2.  Whole-Genome Analyses Reveal Genomic Characteristics and Selection Signatures of Lincang Humped Cattle at the China-Myanmar Border.

Authors:  Luyang Sun; Kaixing Qu; Xiaohui Ma; Quratulain Hanif; Jicai Zhang; Jianyong Liu; Ningbo Chen; Quji Suolang; Chuzhao Lei; Bizhi Huang
Journal:  Front Genet       Date:  2022-03-22       Impact factor: 4.599

3.  Identification and validation of EMT-immune-related prognostic biomarkers CDKN2A, CMTM8 and ILK in colon cancer.

Authors:  Ning Kang; Xiaoli Xie; Xue Zhou; Yijun Wang; Shengxiong Chen; Ran Qi; Ting Liu; Huiqing Jiang
Journal:  BMC Gastroenterol       Date:  2022-04-16       Impact factor: 2.847

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.